Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Adobe (ADBE) upgraded to Buy from Hold at Wunderlich with analyst Ryan Macdonald citing the company's better than expected first quarter results. The analyst raised his price target for the shares to $145 from $115. 2. L Brands (LB) upgraded to Outperform from Market Perform at FBR Capital with analyst Susan Anderson saying her survey work shows that Victoria Secret has not lost share over the past year and that same-store-sales will be better than expected in the second half of 2017. 3. Vertex (VRTX) upgraded to Outperform from Market Perform at JMP Securities with analyst Liisa Bayko saying the company's triple combo data this year could expand its cystic fibrosis patient pool by greater than 50%. Positive triple combo data could make Vertex a takeover target, Bayko adds. 4. Dean Foods (DF) upgraded to Overweight from Neutral at JPMorgan with analyst Ken Goldman raising his estimates to reflect lower raw dairy costs. The outlook for Dean's largest input, Class I milk, has softened in recent months, Goldman tells investors in a research note. The analyst raised his price target for the shares to $22 from $20. 5. Barclays (BCS) upgraded to Overweight from Equal Weight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here

Returns: targeting a greater than 12% RoTE; Capital returns: plan to return at least GBP 10bn of capital to shareholders between 2024 and 2026, through dividends and share buybacks, with a continued preference for buybacks. Plan to keep total dividend stable at 2023 level in absolute terms, with progressive dividend per share growth driven through share count reduction as a result of increased share buybacks. Dividends will continue to be paid semi-annually. This multi-year plan is subject to supervisory and Board approval, anticipated financial performance and our published CET1 ratio target range of 13-14%; Income: targeting Group total income of c.GBP 30bn; Costs: targeting total Group operating expenses of c.GBP 17.0bn and a Group cost: income ratio of high 50s in percentage terms. This includes total gross efficiency savings of c.GBP 2bn by 2026; Impairment: expect an LLR of 50-60bps through the cycle; Capital: expect to operate within the CET1 ratio target range of 13-14%; Targeting IB RWAs of c.50% of Group RWAs in 2026; Impact of regulatory change on RWAs in line with prior guidance, expected to be at lower end of 5-10% of Group RWAs. This includes c.GBP 16bn RWAs expected in H224 due to USCB moving to Internal Ratings-Based models

Returns: targeting RoTE of greater than 10% and c.10.5% excluding inorganic activity; Income: targeting Barclays Group NII excluding IB and Head Office of c.GBP 10.7bn, of which Barclays UK NII of c.GBP 6.1bn; Costs: targeting Group cost: income ratio of c.63%, which includes c.GBP 1bn of gross efficiency savings in 2024; Impairment: expect an LLR of 50-60bps through the cycle; Capital: expect to operate within the CET1 ratio target range of 13-14%.